| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.1M | -5.7% | +12.2% |
| Cost of Revenue | $2.9M | -1.2% | +15.5% |
| Gross Profit | $3.2M | -9.4% | +9.5% |
| R&D Expense | $7.5M | +97.9% | +84.7% |
| SG&A Expense | $2.6M | -10.3% | -11.6% |
| Operating Income | -$6.9M | -116.7% | -70.3% |
| Pre-tax Income | -$3.3M | -4.0% | +17.9% |
| Income Tax | -$251K | -712.2% | -670.5% |
| Net Income | -$3.0M | +5.2% | +25.0% |
| EPS (Basic) | -$0.09 | +18.2% | +43.8% |
| EPS (Diluted) | -$0.09 | +18.2% | +43.8% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $70.7M | +179.0% | +368.5% |
| Accounts Receivable | $2.8M | +76.0% | -21.0% |
| Inventory | $3.9M | +6.7% | -0.2% |
| Current Assets | $79.3M | +142.3% | +233.0% |
| Total Assets | $98.5M | +89.4% | +123.1% |
| Current Liabilities | $7.6M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.5M | — | — |
| Capital Expenditures | $336K | — | — |
| Investing Cash Flow | -$336K | — | — |
| Financing Cash Flow | $68.0M | — | — |
| Free Cash Flow | -$10.8M | — | — |
| +29.0% |
| Total Liabilities | $14.8M | +10.4% | +4.5% |
| Stockholders' Equity | $83.6M | +116.9% | +179.4% |